181 related articles for article (PubMed ID: 26982250)
1. Tobacco Mosaic Virus Delivery of Phenanthriplatin for Cancer therapy.
Czapar AE; Zheng YR; Riddell IA; Shukla S; Awuah SG; Lippard SJ; Steinmetz NF
ACS Nano; 2016 Apr; 10(4):4119-26. PubMed ID: 26982250
[TBL] [Abstract][Full Text] [Related]
2. Speciation of Phenanthriplatin and Its Analogs in the Core of Tobacco Mosaic Virus.
Vernekar AA; Berger G; Czapar AE; Veliz FA; Wang DI; Steinmetz NF; Lippard SJ
J Am Chem Soc; 2018 Mar; 140(12):4279-4287. PubMed ID: 29553267
[TBL] [Abstract][Full Text] [Related]
3. Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile.
Park GY; Wilson JJ; Song Y; Lippard SJ
Proc Natl Acad Sci U S A; 2012 Jul; 109(30):11987-92. PubMed ID: 22773807
[TBL] [Abstract][Full Text] [Related]
4. Tobacco mosaic virus delivery of mitoxantrone for cancer therapy.
Lin RD; Steinmetz NF
Nanoscale; 2018 Aug; 10(34):16307-16313. PubMed ID: 30129956
[TBL] [Abstract][Full Text] [Related]
5. Tobacco Mosaic Virus-Delivered Cisplatin Restores Efficacy in Platinum-Resistant Ovarian Cancer Cells.
Franke CE; Czapar AE; Patel RB; Steinmetz NF
Mol Pharm; 2018 Aug; 15(8):2922-2931. PubMed ID: 28926265
[TBL] [Abstract][Full Text] [Related]
6. Delivery of Cationic Platinum Prodrugs via Reduction Sensitive Polymer for Improved Chemotherapy.
Chen H; Wang Y; Liu Y; Tang L; Mu Q; Yin X; Zheng L; Chen Y; Liu C
Small; 2021 Nov; 17(45):e2101804. PubMed ID: 34554644
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin-Loaded Tobacco Mosaic Virus for Ovarian Cancer Treatment.
Zhao Z; Simms A; Steinmetz NF
Biomacromolecules; 2022 Oct; 23(10):4379-4387. PubMed ID: 36053908
[TBL] [Abstract][Full Text] [Related]
8. The chiral potential of phenanthriplatin and its influence on guanine binding.
Johnstone TC; Lippard SJ
J Am Chem Soc; 2014 Feb; 136(5):2126-34. PubMed ID: 24417436
[TBL] [Abstract][Full Text] [Related]
9. Cancer Theranostic Applications of Albumin-Coated Tobacco Mosaic Virus Nanoparticles.
Pitek AS; Hu H; Shukla S; Steinmetz NF
ACS Appl Mater Interfaces; 2018 Nov; 10(46):39468-39477. PubMed ID: 30403330
[TBL] [Abstract][Full Text] [Related]
10. Effect of a monofunctional phenanthriplatin-DNA adduct on RNA polymerase II transcriptional fidelity and translesion synthesis.
Kellinger MW; Park GY; Chong J; Lippard SJ; Wang D
J Am Chem Soc; 2013 Sep; 135(35):13054-61. PubMed ID: 23927577
[TBL] [Abstract][Full Text] [Related]
11. Structural and mechanistic studies of polymerase η bypass of phenanthriplatin DNA damage.
Gregory MT; Park GY; Johnstone TC; Lee YS; Yang W; Lippard SJ
Proc Natl Acad Sci U S A; 2014 Jun; 111(25):9133-8. PubMed ID: 24927576
[TBL] [Abstract][Full Text] [Related]
12. Featured Article: Delivery of chemotherapeutic vcMMAE using tobacco mosaic virus nanoparticles.
Kernan DL; Wen AM; Pitek AS; Steinmetz NF
Exp Biol Med (Maywood); 2017 Aug; 242(14):1405-1411. PubMed ID: 28675044
[TBL] [Abstract][Full Text] [Related]
13. RNA-Seq Analysis of Cisplatin and the Monofunctional Platinum(II) Complex, Phenanthriplatin, in A549 Non-Small Cell Lung Cancer and IMR90 Lung Fibroblast Cell Lines.
Monroe JD; Moolani SA; Irihamye EN; Speed JS; Gibert Y; Smith ME
Cells; 2020 Dec; 9(12):. PubMed ID: 33302475
[TBL] [Abstract][Full Text] [Related]
14. Phenanthriplatin Acts As a Covalent Poison of Topoisomerase II Cleavage Complexes.
Riddell IA; Agama K; Park GY; Pommier Y; Lippard SJ
ACS Chem Biol; 2016 Nov; 11(11):2996-3001. PubMed ID: 27648475
[TBL] [Abstract][Full Text] [Related]
15. DNA Intercalation Facilitates Efficient DNA-Targeted Covalent Binding of Phenanthriplatin.
Almaqwashi AA; Zhou W; Naufer MN; Riddell IA; Yilmaz ÖH; Lippard SJ; Williams MC
J Am Chem Soc; 2019 Jan; 141(4):1537-1545. PubMed ID: 30599508
[TBL] [Abstract][Full Text] [Related]
16. Understanding and improving platinum anticancer drugs--phenanthriplatin.
Johnstone TC; Park GY; Lippard SJ
Anticancer Res; 2014 Jan; 34(1):471-6. PubMed ID: 24403503
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin.
Riddell IA; Johnstone TC; Park GY; Lippard SJ
Chemistry; 2016 May; 22(22):7574-81. PubMed ID: 27111128
[TBL] [Abstract][Full Text] [Related]
18. Monofunctional platinum(II) compounds and nucleolar stress: is phenanthriplatin unique?
McDevitt CE; Yglesias MV; Mroz AM; Sutton EC; Yang MC; Hendon CH; DeRose VJ
J Biol Inorg Chem; 2019 Sep; 24(6):899-908. PubMed ID: 31494760
[TBL] [Abstract][Full Text] [Related]
19. Tobacco mosaic virus-based protein nanoparticles and nanorods for chemotherapy delivery targeting breast cancer.
Bruckman MA; Czapar AE; VanMeter A; Randolph LN; Steinmetz NF
J Control Release; 2016 Jun; 231():103-13. PubMed ID: 26941034
[TBL] [Abstract][Full Text] [Related]
20. Is the cytotoxic activity of phenanthriplatin dependent on the specific size of the phenanthridine ligand π system?
Scoditti S; Dabbish E; Sicilia E
J Inorg Biochem; 2021 Jun; 219():111447. PubMed ID: 33798829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]